Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
Portuguese (Brazilian)

Clinical Study Results

  • BI 1467335 - Non-alcoholic Fatty Liver Disease
    Clinical Study Number 1386-0004
    Study Indication Non-alcoholic Fatty Liver Disease
    Product BI 1467335
    Generic Name BI 1467335
    Lab Code BI 1467335
    Clinical Phase IIa
    Study Title

    A multicentre, double-blind, parallel-group, randomised, placebo-controlled phase IIa study to investigate safety, tolerability, pharmacodynamics, and pharmacokinetics of different doses of orally administered BI 1467335 during a 12-week treatment period compared to placebo in patients with clinical evidence of NASH

    Study Document
    Trial synopsis 1386-0004 english
    Lay summary 1386-0004 english